ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a malignant proliferative disease derived from BM hematopoietic stem cells, and TKIs function by inhibiting the tyrosine kinase activity of the pathogenic protein BCR::ABL1 in CML cells.